|
regorafenib is a treatment of colorectal cancer medicine
Regorafenib is a multikinase inhibitor (MKI) that targets cancer growth and progression by inhibiting multiple protein kinase.
|
73 % |
|
SPRYCEL® (dasatinib) for Healthcare Professionals
Find SPRYCEL® indicated for the treatment of pediatric patients with newly diagnosed Ph+ acute lymphoblastic leukemia (ALL) with chemotherapy&for adults & ch...
|
71 % |
|
High LDL-C Injection Treatment | Repatha® (evolocumab) HCP
Learn how Repatha® can reduce the risk of major adverse cardiovascular (CV) events and lower high LDL-C in adult patients at increased risk of these events....
|
69 % |
|
BKEMV® for PNH, aHUS, and Adults with AChR-Ab+ gMG & AQP4-Ab+ NMOSD
BKEMV® is indicated for patients with PNH, aHUS, and adult patients with AChR-Ab+ gMG or AQP4-Ab+ NMOSD. See safety info, including boxed WARNING.
|
68 % |
|
MESI-STRAT – Systems Medicine of Metabolic-Signaling networks – A New Conept for Breast Cancer Patient Stratification
|
67 % |
|
BPDCN Treatment | ELZONRIS® (tagraxofusp-erzs)
Evaluate ELZONRIS, the only approved treatment for blastic plasmacytoid dendritic cell neoplasm (BPDCN). See full Prescribing Information, including Boxed WA...
|
67 % |
|
WELIREG® (belzutifan) | Official Patient Website
Learn more about WELIREG® (belzutifan), one oral medicine approved to treat two different conditions. Learn about another treatment option here.
|
67 % |
|
For healthcare professionals | NERLYNX® (neratinib) tablets
NERLYNX® (neratinib) tablets is indicated for the treatment of early-stage HER2+ breast cancer following adjuvant trastuzumab-based therapy and metastatic HE...
|
67 % |
|
Brukinsa®▼ (zanubrutinib)
Information on BRUKINSA (zanubrutinib) intended for healthcare professionals in the UK and Ireland only.
|
67 % |
|
VEPPANU™ (vepdegestrant) Official Website
VEPPANU is indicated for the treatment of adult patients with ER+/HER2–, ESR1m advanced or metastatic breast cancer previously treated with ET. VEPPANU may r...
|
67 % |
|
Power Wellness | Medical Optimization
|
67 % |
|
Home - NPScreen
|
66 % |
|
VEMLIDY® (tenofovir alafenamide) | HCP site
|
66 % |
|
DrugText.org — The Illicit Substance Database
A comprehensive, non-judgmental, open-source archive of pharmacological data, legal status, drug policy, and harm-reduction protocols for psychoactive substa...
|
65 % |
|
indianclinicaltrials – indian clinical trials
|
65 % |
|
Coastal Medical Imaging
Offering a range of clinic services across multiple locations. Contact us for appointments and more information about our services.
|
65 % |
|
Retroactive Medicaid Recovery for Safety Net Providers
RetroCAID monitors every uncompensated encounter and recovers the Retroactive Medicaid revenue eligibility checks miss. 100% contingency.
|
65 % |
|
RENFLEXIS® (infliximab-abda) | Official Patient Web Site
Find information about RENFLEXIS® (infliximab-abda), including how to transition from Remicade® (infliximab) to RENFLEXIS. Talk to your doctor to see if RENF...
|
65 % |
|
Parkinson’s Medication | RYTARY® (carbidopa and levodopa) extended-release capsules for HCP
Learn about RYTARY, a Parkinson’s disease treatment. Watch videos featuring experts, discover dosing strategies, and receive patient resources.
|
65 % |
|
Prescription Support for Patients & Caregivers | Acadia Connect®
|
65 % |
Detected social media networks